article thumbnail

New Study Reveals Simple Blood Test Can Predict Preeclampsia Risk Months Before Symptoms Develop

Scienmag

A groundbreaking study unveiled at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) this week marks a new era in prenatal care, revealing that a simple blood test conducted during the first trimester of pregnancy can predict the development of preeclampsia months before any clinical symptoms arise.

article thumbnail

AI technology for early screening of autism spectrum disorder developed

Medical Xpress

ETRI researchers have developed an artificial intelligence (AI) technique for the early screening of autism spectrum disorder (ASD). The technology is designed to detect early signs of ASD in children more quickly, which could expand opportunities for early screening and intervention and greatly improve accessibility.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New development in stem cell transplant for blood cancers set to change 40 years of standard practice

Medical Xpress

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukemia significantly improves patient outcomes post-transplant, reducing the risk of the life-threatening complication of graft versus host disease (GVHD).

article thumbnail

National Heart Centre Singapore and Mayo Clinic Join Forces to Propel Cardiovascular Care and Research

Scienmag

Beyond cardio-oncology, the partners are uniting around the development of innovative healthcare solutions designed to transform cardiac treatment paradigms. Underlying the partnership’s scientific ambitions is a commitment to translational research and academic development.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Single-Cell Study Uncovers Dup15q Syndrome Autism Changes

Scienmag

What distinguishes this study even further is the identification of molecular changes not only during early brain development but extending into the postnatal period. By generating a detailed cellular atlas of dup15q syndrome, the researchers have created a resource that clinicians and drug developers can use to design targeted interventions.

article thumbnail

Impact of Maternal Age on Infant Development: New Scientific Insights

Scienmag

Older mothers generally exhibit higher body mass indices (BMI), often accompanied by comorbidities such as hypertension and gestational diabetes, which themselves adversely impact fetal development.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

article thumbnail

How to Turn “Check-the-Box” Compliance Trainings Into Real Learning

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

This publication is recognized by SHRM to offer Professional Development Credits (PDCs) for the SHRM-CP® or SHRM-SCP® This program is valid for 1 PDC for the SHRM-CP® or SHRM-SCP® For more information about certification or recertification, please visit www.shrmcertification.org.